from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2705c/-

LFCtreatmentdescriptionclass of inhibitor

1.271

Amikacinug/mL Amikacintranslation

0.632

Cap5-10ug/mL Capreomycintranslation

1.736

Rox10-50 ug/mL Roxithromycintranslation

0.583

SM2-5 ug/mL Streptomycintranslation

0.778

Tet5-10 ug/mL Tetracyclinetranslation

-0.315

Rif0.2-5ug/mL Rifampicintranscription

-0.124

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.890

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.295

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.443

CPZ10-50 ug/mL Chlorpromazinerespiration

1.765

Clofazimine10-13 ug/mL Clofaziminerespiration

0.629

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.361

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.671

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.011

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.079

Econazole10-24 ug/mL Econazole (azole drug)respiration

2.233

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.239

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.284

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.351

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.190

KCN5-20 ug/mL Potassium cyaniderespiration

1.075

NaN30.2-2 mM Sodium aziderespiration

0.440

Nigericin50 uM Nigericinrespiration

-0.461

TRC10-150 ug/mL Triclosanrespiration

-0.485

TRZ10-25 ug/mL Thioridazinerespiration

-0.690

Valinomycin0.5-10 uM Valinomycinrespiration

-1.455

ZnSO42 mM ZnSO4respiration

0.221

menadione6-10 ug/mL Menadionerespiration

1.860

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.080

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.081

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.416

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.680

NRP_1Non-replicating persistence stage 1dosRassociated

-0.072

Amp0.2mg/mL AmpicillincellWall

-0.426

Cephalexin20-100 ug/mL CephalexincellWall

0.602

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.416

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.062

EMB10-20 ug/mL EthambutolcellWall

0.516

Eta12-40 ug/mL EthionamidecellWall

-0.000

INH0.2-0.4 ug/mL IsoniazidcellWall

0.043

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.116

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.033

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.615

BZA0.12 mg/mL BenzamidearomaticAmides

-0.893

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.913

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.195

H2O24 mM hydrogen peroxideDNAdamaging

-0.407

Levo10 ug/mL LevofloxacinDNAdamaging

-0.377

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.734

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.237

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.266

UVUV-irradiationDNAdamaging

0.028

ARP41-4 ug/mL Antitubercular compound ARP4?

0.265

Antimycin12.5-50 ug/mL Antimycin A?

-0.554

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.173

PA_110-50 ug/mL Antitubercular compound PA-1?

0.266

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.326

PA8240.2-2 ug/mL PA-824?

0.354

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.946

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.532

Verapamil50 uM Verapamil?

0.336

mercaptoethanol2 mM 2-Mercaptoethanol?

0.515

methoxatin10-20 ug/mL Methoxatin?